Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have different body composition and some metabolic differences compared to healthy women.

Hirsute women with ovarian-sourced hirsutism are more likely to have irregular periods, with higher BMI and altered hormone ratios.

Treatment improved PCOS symptoms and reduced BMI and certain immune factors.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Acne is strongly linked to high BMI, hair loss, menstrual issues, family history, and eating too many sweets and fatty foods, but not to excessive hair growth.

Lifestyle factors like BMI at young adulthood can increase cancer risk in women with Lynch Syndrome, but diet and height don't seem to affect this risk.

Certain MC4R gene variants are linked to higher BMI in obese women with PCOS but do not cause PCOS.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Some teenagers with anorexia nervosa have worse cognitive abilities, especially in visual and spatial tasks, and this is more common in those with a lower body weight.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Women with PCOS have lower quality of life, especially in mental health and energy, and managing weight can help improve it.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Metformin helps with PCOS symptoms no matter the patient's initial insulin resistance or weight.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Women with Polycystic Ovary Syndrome have higher levels of the hormone ghrelin, which may be linked to the cause of the condition.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Adults with certain skin conditions may have higher levels of inflammation in their body.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

People with vitiligo may have a lower risk of heart disease.

Twisted hair is rare in severe anorexia nervosa, found in only 2 out of 30 patients.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.